Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance. by Naylor, Nichola R et al.
One Health 11 (2021) 100194
Available online 14 November 2020
2352-7714/© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Quantitatively evaluating the cross-sectoral and One Health impact of 
interventions: A scoping review and case study of antimicrobial resistance 
Nichola R. Naylor a,*, Jo Lines a, Jeff Waage a, Barbara Wieland b, Gwenan M. Knight a 
a London School of Hygiene & Tropical Medicine, London, United Kingdom 
b International Livestock Research Institute (ILRI), Addis Ababa, Ethiopia   






A B S T R A C T   
Background: Current frameworks evaluating One Health (OH) interventions focus on intervention-design and 
-implementation. Cross-sectoral impact evaluations are needed to more effectively tackle OH-issues, such as 
antimicrobial resistance (AMR). We aimed to describe quantitative evaluation methods for interventions related 
to OH and cross-sectoral issues, to propose an explicit approach for evaluating such interventions, and to apply 
this approach to AMR. 
Methods: A scoping review was performed using WebofScience, EconLit, PubMed and gray literature. Quanti-
tative evaluations of interventions that had an impact across two or more of the human, animal and environment 
sectors were included. Information on the interventions, methods and outcome measures found was narratively 
summarised. The information from this review informed the construction of a new approach to OH-related 
intervention evaluation, which then was applied to the field of AMR. 
Results: The review included 90 studies: 73 individual evaluations (from 72 papers) and 18 reviews, with a range 
of statistical modelling (n = 13 studies), mathematical modelling (n = 53) and index-creation/preference- 
ranking (n = 14) methods discussed. The literature highlighted the need to (I) establish stakeholder objec-
tives, (II) establish quantifiable outcomes that feed into those objectives, (III) establish agents and compartments 
that affect these outcomes and (IV) select appropriate methods (described in this review) accordingly. Based on 
this, an evaluation model for AMR was conceptualised; a decision-tree of intervention options, a compartmental- 
microeconomic model across sectors and a general-equilibrium (macroeconomic) model are linked. The out-
comes of this multi-level model (including cost-utility and Gross Domestic Product impact) can then feed into 
multi-criteria-decision analyses that weigh respective impact estimates alongside other chosen outcome esti-
mates (for example equity or uncertainty). 
Conclusion: In conclusion, stakeholder objectives are key in establishing which evaluation methods (and asso-
ciated outcome measures) should be used for OH-related interventions. The stated multi-level approach also 
allows for sub-systems to be modelled in succession, where resources are constrained.   
1. Introduction 
Antimicrobial resistance (AMR) may reduce our ability to prevent 
and treat infections in humans and animals [1]. It has been described as 
a true One Health (OH) issue [2–4], in which OH can be defined as the 
description of, and interactions between, the individual, population and 
ecosystem levels of health (across humans, animals, plants and the wider 
environment) [5]. For the purposes of this paper, ‘cross-sectoral’ relates 
to the interaction between two or more of these ecosystem factors 
(human, animal and ‘plants and environment’). 
Policy options to tackle the emergence and spread of AMR have been 
put forward through international policy reports and action plans [6,7]. 
While there is some evidence of a positive effect of reducing antimi-
crobial use in food-producing animals on AMR outcomes in humans [8], 
there is a lack of evidence that quantifies the wider socio-economic and 
OH impact [9,10]. The Network for Evaluation of One Health (NEOH) is 
one of various initiatives offering frameworks for evaluation in OH 
topics [11,12]. However, the NEOH do not propose a specific framework 
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for how to perform economic impact evaluations of AMR interventions 
from a OH-perspective. Methods for evaluating AMR-burden and related 
intervention impact have been proposed [10], but mainly from a human- 
health perspective. 
In the OH literature, two key literature reviews highlight potential 
quantitative outcomes useful in evaluating OH interventions. However, 
these reviews do not discuss in detail methods of how to model cost 
outcomes nor offer an explicit approach to cover multiple outcomes 
[13,14]. Given the complexity of integrating OH evaluations across 
different sectors, existing economic evaluation checklists do not offer an 
appropriate discussion of the health and/or economic impact of cross- 
sectoral interventions [15]. Such discussion on complex, OH interven-
tion evaluation is needed for the field to obtain robust estimates of 
resulting intervention impacts. 
It has previously been highlighted that AMR poses similar theoretical 
evaluation issues to climate change and zoonotic infections, due to their 
cross-sectoral nature and/or link with greater societal costs due to in-
dividual behaviours [16–18]. Hence there is scope to learn from, and 
adapt, existing cross-sectoral evaluation approaches from these topics 
within the field of AMR. 
This study therefore aims to (i) collate and describe previous 
methods used in the quantitative evaluation of interventions related to 
OH and other cross-sectoral issues, (ii) offer an explicit approach for 
evaluating such interventions, and (iii) apply this approach to the case of 
AMR-related interventions. 
2. Materials and methods 
A scoping review allows for the identification of main concepts 
within a particular area of interest [19]. Therefore, a scoping review 
method was used to achieve our first objective. Retrievals that the au-
thors thought were likely to provide a high inclusion rate of relevant 
literature (such as OH surveillance and climate change [18])) were 
sought. Within WebofScience, EconLit and Google the following search 
strings were used [20–22]; (1) (“One Health” AND “evaluation”), (2) 
(“economic” AND “evaluation” AND “health” AND “agriculture”), (3) 
(“economic” AND “evaluation” AND “climate change”). An additional 
search was conducted in PubMed utilising (“One Health” AND surveil-
lance AND economic evaluation) [23], with 28th March 2019 being the 
last search date for all searches. A protocol for this study was not pub-
lished, but the reporting of this scoping review is aligned with the 
PRISMA-ScR checklist (see Appendix A). 
Titles were reviewed by the lead author, followed by abstracts (if 
available), and subsequently full texts (if available). A study was 
included if it contained quantitative impact estimates across more than 
one sector (human, animal and environment) within the intervention 
evaluation. See Table 1 for the inclusion and exclusion criteria applied. 
Reference lists were also used to identify additional literature. 
For each evaluation study, the OH issue, intervention, spatial and 
temporal scope, main method, main data source, key inputs, key outputs 
(monetary and non-monetary) and potential limitations were noted 
using a data extraction table (see Appendix D). Summary indicators 
were used (see Table 2). Relevant literature reviews were included, with 
their aims and results summarised separately (see Appendix C). Due to 
the research aims, and study design heterogeneity, no risk of bias 
checklist was used. 
Results are presented descriptively, with key concepts found high-
lighted. This is then used to propose an explicit approach for evaluating 
OH interventions. This proposed approach was then applied to AMR- 
interventions, along with AMR-based literature, to construct a concep-
tual evaluation model. A visual schematic of this conceptual model was 
drafted and narratively discussed. 
3. Results 
3.1. Literature characteristics 
1479 unique retrievals followed by 168 full texts were screened from 
the formal searches, leading to 65 studies being included. The majority 
of texts were excluded due to either not evaluating an intervention/ 
policy or only evaluating within one sector. Through reference lists and 
Google searches, an additional 25 papers were added. 72 evaluation 
studies (73 individual evaluations) and 18 literature reviews were 
included. All individual studies included human impact (73 evalua-
tions), with more including environmental than animal impact (see 
Appendix B). Only 29 (40%) of the 73 evaluations included all 3 per-
spectives. The majority of studies covered only one evaluation per-
spectives (39/73), usually either micro- or macroeconomic, with 29 
having two evaluation perspectives and 5 studies covering all three. 
Interventions were tackling issues associated with climate change (38/ 
73), zoonotic infections (21/73), antimicrobial resistance (1/73) or 
other cross-sectoral issues (11/73). 
3.2. Frameworks & approaches proposed and used in cross-sectoral 
evaluation 
A number of the reviews offered a guide/framework to the approach 
of cross-sectoral evaluation [12,16,27–29]. Previous reviews highlight 
the need to involve stakeholders throughout the evaluation process, and 
tailor evaluations according to stake-holder objectives which have been 
defined clearly (e.g. maximizing population health or monetary gains) 
[16,25,28,30–33]. One review on the use of ‘farm models’ in policy (for 
example looking at the economic, environmental and/or social impact 
of different Common Agricultural Policy initiatives) highlighted the 
importance of considering the end-user and involving stakeholders 
when developing such models, however it found that only 23% of the 
Table 1 
Inclusion/exclusion criteria applied in the scoping review. Layout using a PICOS 
criteria approach [24], with the addition of the “Study Type” and “Language” 
categories.  
Criteria Inclusion Exclusion 
Population Human, animal, agriculture, 
environment, economy 
No outcomes or evaluation 
including at least two of the 
stated populations of interest 
(human, animal, agriculture, 
environment, economy) 
Intervention An intervention that is aimed at 
tackling a One Health or cross- 
sectoral issue 
No specific intervention or policy 
Comparator Standard practice/Do nothing/ 
business-as-usual 
No exclusion criteria applied 
Alternative interventions/ 
policy scenarios 
Outcome Quantitative outcome No quantitative outcomes 
Quantitative outcomes in only 
one sector (e.g. only energy costs 




Economic Model No specific exclusion criteria 
applied 
Mathematical Model  
Statistical Model  
Observational study 
(randomised controlled trial, 
case-control or cohort)  
Review (separately included 
from individual studies)  
Study type Peer-reviewed Publication Letters 
Reports Case studies (descriptive) 
Book and/or Book Chapter Conference Abstracts 
Protocol 
Language English   
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184 studies reported stakeholder consultation [30]. 
Other concepts highlighted through previous reviews and proposed 
frameworks include; incorporating all plausible scenarios 
[12,16,25,29], stress-testing models with extreme scenarios [16,27,29], 
allowing for iterations over-time [29,32,34], quantifying distributions 
of effects [13,35,36] and explicitly discussing uncertainty [29,33,37]. 
3.3. Outcome measures used in cross-sectoral evaluation 
Out of the 73 individual studies that underwent data extraction, 52 
(72%) and 45 (62%) had main outcomes of non-monetary and monetary 
valuations respectively. 24 of these (33%) included both, with 6 
including impact on human health burden and monetary outcomes 
[17,38–42]. Many of these were climate change/emissions related in-
terventions (15/24) that included an emissions (environmental) impact 
and a subsequent cost/Gross Domestic Product (GDP) Impact. 
Morbidity measures were based on utility and welfare (such as 
animal welfare scores for animal impact [40]). Disability Adjusted Life 
Years (DALYs) were used in some evaluations, combining both mortality 
and morbidity impacts in relation to human impact [17,40,42,43]. Cost 
per DALY averted outcomes were compared to stated monetary, 
willingness-to-pay thresholds (such as $30,000 per DALY averted) to 
conclude whether animal vaccination was cost-effective from a OH 
perspective in two of the studies found [17,43]. In some of the envi-
ronmental science literature, monetary values of health outcomes were 
termed as the “value for statistical life” (such as 40,000 EUR per loss of 
life year [44]) [39]. Discussion on how to elicit or calculate ‘willingness- 
to-pay thresholds’ and monetary life-year values is available [33,45]. 
Cost-benefit and cost-utility outcomes were also highlighted in included 
literature reviews (see Appendix C) [13,14,27,30,36]. 
Other potentially important monetary outcomes emphasised by 
previous reviews include profit, income, stakeholder cost-savings and 
productivity valuations [13,14,27,30,33]. Whilst human, social and 
economic development indicators, environmental sustainability, biodi-
versity, equality, equity and ethical implications were highlighted as key 
non-monetary outcomes [13,14,27,30,33,34,36]. 
3.4. Methods used in cross-sectoral evaluation 
Thirteen studies used statistical evaluation techniques; including 
regression modelling [46,47], trend analysis [48,49] and basic 
descriptive statistics [50,51] to estimate the size of the intervention 
impact or summarise outcome measures on a particular population, 
respectively. Estimates of different levels of burden (from different 
perspectives) based on statistical analyses can feed into mathematical 
model-based evaluations [25], such as that used for the economic 
evaluation of climate protection measures in Germany [52]. This study 
performed econometric evaluations of energy (e.g. price) and economy 
(e.g. national account) data to estimate mathematical model parameter 
values that fed into structural equations. This allowed them to forecast 
the impact of interventions, such as the ‘Energy Transformation Sce-
nario’, on GDP and related components (e.g. sector employment). 
The majority of studies analysed (53/73) used mathematical simu-
lations to estimate cross-sectoral impact, which included not only cost- 
benefit and cost-utility analyses (10/73), but also basic calculations, 
computable general equilibrium and systems dynamics models (see 
Appendix D). 
Hutton suggests performing both cost-benefit and cost-utility ana-
lyses simultaneously, providing both cost-benefit ratios and cost per 
DALY averted respectively for relevant stakeholders [33]. One micro-
economic evaluation study which provided both monetary and non- 
monetary outcomes for a range of stakeholder perspectives was on 
rabies vaccination [40]. This study separated potential outcome mea-
sures useful to different decision-makers, such as monetary expenditure, 
DALYs averted, animal welfare and dog acceptance (the latter two being 
“qualitative scores”) and estimated uncertainty through probabilistic 
sensitivity analysis [40]. In contrast, few of the studies found using 
computable general equilibrium analyses and systems dynamics models 
explicitly quantified uncertainty, instead including scenario analyses 
only [53,54]. The ECONADAPT toolbox provides a useful list of methods 
that explicitly incorporate uncertainty [37]. 
Finally, fourteen studies used ‘index creation’ methods (see Table 2 
for definition), with six using multi-criteria decision analysis (MCDA) 
and 8 using “One Health-ness” indices [55–62]. The latter may be useful 
if a stakeholder views ‘OH-ness’ as an important factor within their 
assessment of the effectiveness of interventions [12]. One example of 
MCDA application was in Lyme disease management strategies [63], 
where multiple interventions were ranked based on public health, ani-
mal, environmental and social impact as well as economic, strategic, 
operational and surveillance criteria [63]. However, in order to rank 
policies based on criteria such as “reduction on incidence of human 
cases” and “impact on cost to public sector”, the outputs of epidemio-
logical and health economic models are needed. In this example, these 
Table 2 
Scoping review indicator definitions.  
Indicator* Classification Definition 
One Health 
perspective 
Human Impact quantified on a person; 
including patients, consumers and 
farmers within the system under 
evaluation. 
Animal Impact quantified on animals; 
including livestock, fish, 
companion animals. 
Environment Impact quantified on the 
environment, including on 




Individuals Evaluating impact on health 




Evaluating impact within one 
specific sector; such as health care, 
environmental and agricultural 
sectors individually. It also 
included individual business 
impact, such as farm-level impact. 
Macroeconomic (Multi- 
sector and Government) 
Evaluating impact across multiple 






Methods which take a hypothetical 
sample and model potential 
interactions and/or outcomes using 
mathematical formulae. This 
ranges from simple stepwise 
calculation methods (e.g. applying 
prevalence levels to a population of 
interest) to complex system 
dynamic models and general 
computable equilibrium models 
[25]. 
Statistical Evaluation Methods which take empirical data 
and apply statistical methods to 
estimate interactions and/or 
associated outcomes. This ranges 
from the calculation of descriptive 
statistics to complex survival 
analyses and regression analyses 
[25]. 
Index/Rank Creation & 
Calculation 
Methods which utilise a framework 
to compile an index to measure the 
intervention, or a formalised 
ranking system. For example, 
multi-criteria decision analyses 
[26]. 
Other If the study method did not fit into 
any of the above methodology 
perspective categories, then Other 
was used.  
* These refer to the intervention evaluation perspective. 
N.R. Naylor et al.                                                                                                                                                                                                                               
One Health 11 (2021) 100194
4
outcomes were estimated through literature reviews and/or expert 
panels [63]. MCDA methods can also explicitly incorporate equity and/ 
or uncertainty impacts of interventions [37,64]. 
Aside from the aforementioned methods of modelling, the scoping 
review also found scope for linking and extending previous mathemat-
ical and economic models within the field of climate change mitigation 
intervention evaluation [52]. An example is the dynamic climate- 
economic computable general equilibrium model (‘GDynE’). This was 
previously adapted from a similar previous model (‘GDyn’), was linked 
with the ‘Global Trade Analysis Project -Power’ database to create a 
computable general equilibrium model and a cost-benefit analysis to 
estimate the global net monetary impact of climate change mitigation 
policy [65]. Another study applied the NAADSM (North American An-
imal Disease Spread Model) to Influenza transmission across swine and 
humans in Canada [66]. 
3.5. Assumptions in cross-sectoral evaluation 
Most studies included in this review had a time-horizon (the length of 
time of the evaluation) of less than 50 years (15/73 studies used less 
than or equal to one year, 35/73 between 10 and 50 years). Those that 
had longer time-horizons (14/73 studies had 50+ years1) tended to have 
a macroeconomic approach and use computable general equilibrium, 
cost-benefit or MCDA approaches. The majority of papers that had a 
time horizon of less than 10 years were using statistical evaluations of 
data or collecting information to create indices. Such studies are 
generally limited by the time period of data collection. Further use of 
time-series data across a longer time-horizon would be useful in un-
derstanding and forecasting the longer-term burden associated with 
interventions targeting such issues [67]. 
A discount rate is a factor which accounts for stakeholders’ time 
preference. This factor allows users to value future benefits/costs (for 
example healthcare costs in the year 2050) in today’s` values [68]. 
Reviewed studies used discount rates ranging from 1% to 9% [69,70], 
with some utilising a social discount rate which varied over time [27,71] 
and some testing multiple discount rates through scenario analyses 
[70,72,73]. 
3.6. An approach for One Health intervention impact evaluation 
The review highlighted that to evaluate OH intervention impact one 
should (1) define the evaluation-related research question explicitly 
(including all relevant scenarios), (2) define the system (inputs, outputs 
and interactions) and theory of change, and (3) consider appropriate 
methods that capture the whole system that is impacted by changes 
through the intervention, and value outcomes accordingly 
[12,16,27,28]. We build on this by specifying a framework to perform 
part (3), broken down into steps (I) to (IV) below.  
(I) Establish stakeholder objectives (‘objective functions’): In 
Table 3 we list possible objectives of these different agents within 
a potential OH system, drawing on examples from the wider 
literature. The main economic theories used in the selection of 
potential objectives in Table 3 are grounded in utilitarianism 
(maximizing overall ‘satisfaction’) as the main social justice 
perspective. However, the possibility to include egalitarian mo-
tives or capability approaches (focusing on equality and capa-
bility across populations respectively) is also noted [74]. 
Uncertainty was highlighted in previous reviews as something 
that should be explicitly considered and quantified, as this has 
been consistently stated as being valued by decision makers 
[30,32,33,64]. Ideally this would be performed with the 
involvement of stakeholders (e.g. through formal stakeholder 
participation methods that can deal with conflicting objectives 
[75]).  
(II) Establish what components of those objective functions should be 
estimated: Based on the research question, system, theory of 
change and objective function definitions, the components of the 
objective functions that may be impacted by the intervention can 
be highlighted. By providing outcome estimates (such as net in-
come impact) that feed into stakeholder objective functions (such 
as net income maximisation), the intervention evaluation pro-
vides information that can then aid changes in decision making 
(such as whether to uptake, continue or stop use of an interven-
tion as it reduces net income).  
(III) Establish which agents from the system (such as patients/ 
farmers) and/or compartments (such as human/animal health 
states) may affect these outcomes. 
(IV) Select methods that allow for the modelling of interactions be-
tween agents, compartments and selected outcomes. Things to 
consider here include:  
a. If it is a large system with many agents and/or compartments, 
can it be broken down into sub-systems? These can then be 
linked to other available models or expanded on in the future.  
b. Within the chosen system, which modelling method is robust 
and feasible? Potential modelling methods and limitations are 
discussed in the scoping review (see study methods described 
in Appendices C and D). 
c. Are data sources available and accessible for associated sta-
tistical analyses and/or literature available for parameter-
isation of such a model? 
3.7. A case study: antimicrobial resistance and associated interventions 
We apply the above framework to AMR interventions in order to 
provide a clear example of use of the framework. We do not specify the 
intervention itself but take a broader AMR overview.  
(1) Define Research aim: 
To estimate the impact of an intervention aimed at tackling AMR. In 
practice, this would be defined by many specifics, with a linked anti-
microbial, species, infection type etc.  
(2) Define System and theory of change: 
A published systems map of ‘resource systems’, ‘resource units’ and 
‘governing systems’ for AMR was adapted [79]. Our adaptation re-
focuses the system to define agents, actions, resources and sectors [79] 
in line with our proposed framework (see Fig. 1). For example, one 
intervention could be antimicrobial stewardship with a simplified the-
ory of change that stewardship reduces antimicrobial usage, which in 
turn reduces AMR emergence.  
(3) Select methods for intervention impact evaluation: 
(I) & (II) Establish stakeholder objective functions and outcomes: 
Through combining Fig. 1 (outlining stakeholders) and Table 3 
(outlining potential objective functions), we provide potential factors 
and outcomes in Table 4. Uncertainty across all the individual compo-
nents is suggested to be quantified where possible.  
(III) Establish from the system which agents and/or compartments 
affect selected outcomes: 
Through Fig. 1, Tables 1 and 4, we can see that the general public, 
famers, prescribers, ministries across OH and the government in general 
1 The remainder of the 73 did not state a time horizon or it was not 
applicable. 
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may affect outcomes. The health state of humans and animals, which is 
affected by antimicrobial availability, use and AMR, in turn effects 
sector costs and productivity. Pharmaceutical company profit calcula-
tions are business-sensitive information and evaluation methods that 
feed into their decision-making processes were beyond the scope of this 
paper.  
(IV) Selecting an appropriate modelling methodology: 
Previous methods used within and across sectors in evaluating AMR 
and AMR-interventions have been discussed [80], with relevant papers 
cited throughout this section. From the initial conceptual evaluation 
illustrated in Fig. 2, we can see which parameters are needed for the 
proposed decision tree (A) and compartmental model (B). Statistical 
data analyses could be used to parametrise important factors such as: 
trends in resistance levels, demography of the populations of interest, 
specific factor productivity levels and outcomes associated with anti-
microbial susceptible and resistant infections (across humans and ani-
mals) [81–83]. Data on antimicrobial usage, resistance and patient 
outcomes are becoming more available [82,84,85]. 
The selection of models depicted in Fig. 2(B) and (C) allows for the 
outputs of one model to become the inputs of the next. The compart-
mental model structure in Fig. 2(B) also allows for the emergence and 
transmission of AMR to be modelled with the attachment of monetary 
benefits to the human healthcare system (such as applying a monetary 
value per life years lost) [86,87], allowing for an aggregation of mon-
etary costs and benefits across human healthcare and livestock systems, 
giving a cross-sectoral cost-benefit estimate. Additionally, DALYs (or 
Quality Adjusted Life Years) can be attached to give cost-utility values 
[87]. Humans or animals may transition across any of the health states 
within each segment (Fig. 2(B)). However, in the general equilibrium 
model, the compartments are agent states for which changes of eco-
nomic inputs (e.g. labour) and outputs (e.g. product) occur through 
mathematical functions for definitions of agent behaviour [88,89], 
scenario analyses (with stress-testing) and sensitivity analyses can be 
used to quantify methodological and parameter uncertainty [90]. Such 
methods can be extended to also look at poverty impacts [88]. 
Given that the implementation of AMR policy is over multiple years 
and affects multiple cohorts, the evaluation model could be multi-cohort 
(i.e. not just following one “average” cohort of humans and animals over 
Fig. 1. The system under evaluation for cross-sectoral an antimicrobial resistance intervention: Adapted from Ruegg et al [79] (Fig. 2). 
Ovals represent sectors, boxes represent agents, hexagons represent resources and parallelograms represent actions related to antimicrobial stewardship. Connecting 
lines represent potential relationships related to the issue and intervention. ‘Ministry’ may be multiple ministries in reality (for example, food system may include 
commerce and additional governmental offices). AMR: antimicrobial resistance. 
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time). Sub-group analyses across the model would allow for equity 
measures to be available for the MCDA stage of evaluation. The life- 
expectancy of the population included within the models is suggested 
to be the model time-horizon, however outcomes can be estimated at 
earlier time points if needed according to the decision-maker’s objective 
functions. Appropriate discount rates and willingness-to-pay thresholds 
should be used accordingly [91]. 
The proposed structure allows for different levels to be built 
concurrently or subsequently by multiple parties. Allowing for a struc-
tured integration of knowledge accumulation and parameterisation over 
time. Utilising the model-sharing and -adaptation approach seen in the 
climate change literature, this could be feasible to complete in the me-
dium term. Once built, the model could also be expanded to allow more 
complex structures and feedback mechanisms to be integrated, such as 
those in system dynamics models [92]. 
Table 3 
Potential economic agent objectives and constraints.  
Agent Potential objectives and 
constraints 
Example(s) from the literature 
Individuals Individuals may seek to 
maximize individual expected 
utility over their lifetime (or 
over other pre-defined time 
horizons), based on savings, 
consumption of commodities 
and consumption of leisure. 
This includes the consumption 
of healthcare. This will be 
subject to budget constraints (a 
function of income). 
Broadening this, individuals 
could also seek to maximize 
individual capability [74]. 
Smith et al. directly define a 
utility maximisation problem 
using equations involving utility 
values attributed to the 
consumption of commodities 
and leisure, solved using 
computable general equilibrium 
techniques [76]. 
Firm Firms may seek to maximize 
utility (a function of profits), 
based on the consumption of 
labour, capital and intermediate 
inputs, subject to the price of 
the inputs and output. However, 
risk or uncertainty may also 
factor into decision making 
processes of firms.Time 
horizons, over which a firm’s 
objective function is maximised, 
will depend on the nature of the 
production process and 
individual firms (for example 
this could be per quarter, 
financial year or crop cycle). 
A review of farm-level 
evaluations found that half of the 
studies used profit maximisation 
as the objective function, 29% 
included risk or stochasticity, 
whilst 18% of the studies used 
multi-criteria objective functions 
(including income, risk and 
labour factors) [30].A study on 
water resource management 
adaptation policies discussed 
how utility maximisation is often 
equated to profit maximisation 
for firms. However this study 
proposes using a multi-attribute 
utility maximisation when using 
a firm perspective, with factors 
such as risk avoidance and 
management complexity 
included [77]. 
Sector These decision makers may be 
attempting to maximize the 
return on an investment within 
that sector. This could involve 
maximizing the expected 
health-related quality of life or 
monetary return of a given 
investment, or maximizing 
productivity (rate of such 
outputs for a given set of 
inputs), constrained by different 
financing issues depending on 
the sector and its context (e.g. 
public versus private). These 
factors will also impact the 
desired time horizon for which 
the objective maximisation 
process is considered.Increasing 
population capability could 
alternatively be the motivation, 
either through maximisation of 
total capability or through 
meeting a threshold level of 
capacity for as many people in 
society as possible [74]. 
By using cost-utility analyses, 
such as estimating cost per 
disability-adjusted life year 
averted [43], studies assumed 
that payers want to maximize 
expected population utility, 
subject to budget constraints.In 
cost-benefit analyses which 
apply a set monetary value to 
life/utility, there is an 
assumption that a positive return 
on investment is the goal of the 
intended sector [44]. 
Government A general objective function 
proposed for a nation’s 
government is that of 
maximizing government utility 
from the consumption of 
commodities, capital and 
labour, constrained by tax 
revenues [76], and loans or 
other financing mechanisms. 
Government utility, however, 
could encompass wider social 
preferences in the form of being 
a function of equity, capability 
and risk/uncertainty.Chosen 
Previous reviews highlighted the 
importance of outcomes such as 
equity, capability, sustainability, 
uncertainty and animal welfare 
[13,30,33,64]. A social cost- 
benefit analysis included various 
social discount rates alongside a 
survey on what the appropriate 
discount rate would be [71]. 
Economic agent objectives were 
incorporated into a climate 
change policy evaluation found 
in this review in the form of a 
‘multi-level model’. This allowed  
Table 3 (continued ) 
Agent Potential objectives and 
constraints 
Example(s) from the literature 
time horizons and time 
preference assumptions may 
differ depending on policy 
perspectives and external forces 
(such as political election or 
budgetary cycles). 
for an international level and 
lower levels to be linked and was 
based on a game of negotiations, 
using an underlying multi- 
attribute utility function [78]. 
One review found highlighted 
the lack of agricultural/food- 
security evaluations that 
included potentially important 
criteria such as economic 
development and environmental 
sustainability [36].  
Table 4 
Potential Objective Function Factors and Related Outcomes for the Case Study.  
Stakeholder Objective function 
factor 
Measurable outcome 
Individuals (patient, the 
public)  
• Net income  
• Utility  
• Employment rates  
• Per capita net income  
• Mortality  





• Income  
• Revenue  
• Profit  
• Risk  
• Firm income, costs, profit  
• Firm productivity  
• Cost-benefit 
Sector – Human 
Healthcare System (e. 
g. Minister)  
• Cost  
• Mortality  
• Morbidity/Utility  
• Budget  
• Mortality rates and/or case 
fatality rates  
• Infection epidemiology  
• Cost-effectiveness  
• Cost-utility  
• Budget-impact 
Sectors – Agriculture 
and Food Systems  
• Cost  
• Sector 
productivity  
• Budget  
• Nutrition  
• Cost-benefit  
• Productivity  
• Mortality rates and/or case 
fatality rates  
• Infection epidemiology  
• Cost-utility related to 
malnutrition 




• Pollution  
• Biodiversity  
• Environmental 
contamination (e.g. through 
residues or resistant 
microbes) 
Government  • National 
productivity and 
accounts  
• Population utility  
• Cost-benefit  
• Equity  
• Risk  
• Gross domestic Product  
• Population mortality & 
morbidity  
• Infection epidemiology  
• Environmental resource  
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4. Discussion 
We utilise evidence from 90 previous studies and reviews to describe 
previous methods used in evaluating interventions across sectors. Of the 
73 individual evaluations included, the majority of studies; (i) focused 
on only two sectors, (ii) only had one evaluation perspective (e.g. mi-
croeconomic) and (iii) only had either monetary or non-monetary out-
comes (not both). Through narrative discussion of the methods and 
outcomes used in these studies, teamed with concepts from previous 
literature reviews and evaluation frameworks highlighted, we establish 
an explicit valuation approach. We propose impact evaluations of OH- 
interventions (I) establish stakeholder objectives, (II) establish 
quantifiable outcomes that feed into those objectives, (III) establish 
agents and compartments that affect these outcomes and (IV) select 
appropriate methods accordingly (detailed in this paper and within the 
individual study summaries found in Appendix D). 
Through applying our suggested approach to the case study of AMR, 
we propose evaluations of AMR-interventions take a multi-level 
compartmental modelling approach. However, this is based on 
assumed objective functions from the authors, and was not defined 
through stakeholder participation, which is recommended for future 
work. In future evaluations, it may be determined from initial stake-
holder involvement that the proposed outcome measures of this work 
are not wholly applicable. In this instance, the literature review’s 
Fig. 2. A conceptual multi-level model for evaluating cross-sectoral antimicrobial resistance interventions. 
White boxes represent health states or sector states. Segments (A) to (D) represent the model method. Shaded boxes represent settings in (A) – (C) and respective 
model results in (D). Transitions can occur between white boxes within each segment (including across setting), such as from animal antimicrobial susceptible carrier 
to antimicrobial susceptible human carrier within (B), but these lines have not been added for visual simplicity. Inputs refer to those changed through the inter-
vention and not all model inputs. Abbreviations: AMR – antimicrobial resistance, AMS – antimicrobial susceptible, 
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narrative results can still act as a resource for alternative methods used 
in other evaluations of cross-sectoral interventions’ impact. 
In terms of generalisability, our approach can be applied across 
different OH intervention evaluations. Furthermore, as our definition of 
the system and theory of change used in constructing the proposed 
conceptual model for evaluation is generic and simplified, it can be 
adapted and built on to suit local needs for AMR-intervention evalua-
tion. For example, additional compartments related to nutrition- 
associated health states could be added if it is thought the AMR- 
intervention could affect food availability or farmer income. 
In terms of comparing the findings from the review to similar pub-
lished evidence, we found around a third of individual studies had both 
monetary and non-monetary outcomes, which is line with another re-
view focused on outcomes of OH interventions (which also found around 
one third of studies to have both outcome types) [14] . Though a limi-
tation of both is the focus on quantitative outcome assessment, as 
opposed to including also qualitative ones. However, this distinction is 
needed as methods for establishing the former are quite different from 
the latter. 
Our scoping review had limitations. Our chosen method allowed for 
targeted searches relating to relevant areas (such as climate change 
literature [18]) for a narrative discussion of methods, but subsequently 
means that that quoted study proportions of OH issues should not be 
taken as robustly representative of the total research space. Addition-
ally, literature review results were included as outputs themselves, and 
individual studies from those literature reviews were not then re-data- 
extracted, as we wanted to focus on summarising information without 
duplication of effort. However, this limits the generalisability of pre-
sented descriptive statistics across the total research space. Finally, the 
conceptual model for AMR attempts to simplify the modelling proced-
ures, however, a lot of data, time and monetary resources are needed to 
apply the proposed model in practice. 
In conclusion, defining not only the system and theory of change, but 
stakeholder objective functions and associated outcomes is needed for 
impact evaluations of OH interventions to be useful in stakeholder de-
cision making. Compartmental modelling (utilising outputs from sta-
tistical analyses of data and inputs from stakeholders) combined with 
MCDA can allow for AMR interventions to be quantitatively evaluated in 
a way that maximises evaluation utility for decision-makers across the 
OH system. 
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